SCHEMBL265463

SCHEMBL265463

CCN(CC)CCN(C)Cc1ccc(C(=O)Nc2ccc(Br)cc2C(=O)N/N=C/c2ccc(OC)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.53
MAPT P10636 8/20 0.53
HPGD P15428 6/20 0.53
ALDH1A1 P00352 5/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
MEN1 O00255 6/20 0.47
KMT2A Q03164 6/20 0.47
NPSR1 Q6W5P4 2/20 0.47
PKM P14618 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALOX12 P18054 1/20 0.47
LMNA P02545 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
POLB P06746 3/20 0.43
GAA P10253 1/20 0.43
ASF1A Q9Y294 1/20 0.41
HIF1A Q16665 1/20 0.41
MIF P14174 1/20 0.40
F10 P00742 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL265464 1.00 KDM4E (0.53) KDM4EMAPTHPGDALDH1A1NPC1
SCHEMBL266909 0.92 HPGD (0.53) KDM4EMAPTHPGDALDH1A1NPC1
SCHEMBL266908 0.92 HPGD (0.53) KDM4EMAPTHPGDALDH1A1NPC1
SCHEMBL267710 0.91 ALDH1A1 (0.42) KDM4EMAPTHPGDALDH1A1NPC1
SCHEMBL267711 0.91 ALDH1A1 (0.42) KDM4EMAPTHPGDALDH1A1NPC1
SCHEMBL266481 0.91 MEN1 (0.49) KDM4EMAPTHPGDALDH1A1NPC1
SCHEMBL266480 0.91 MEN1 (0.49) KDM4EMAPTHPGDALDH1A1NPC1
SCHEMBL265884 0.88 KDM4E (0.41) KDM4EMAPTHPGDALDH1A1NPC1
SCHEMBL265883 0.88 KDM4E (0.41) KDM4EMAPTHPGDALDH1A1NPC1
SCHEMBL266940 0.88 MAPT (0.53) KDM4EMAPTHPGDALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120115851-A1 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-05-10 US disclosed
US-20120115851-A1 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-05-10 US disclosed
US-20120115851-A1 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-05-10 US disclosed
US-8134015-B2 Compound inhibiting in vivo phosphorous transport and medicine containing the same KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-03-13 US disclosed
US-20060217426-A1 Compound inhibiting in vivo phosphorous transport and medicine containing the same KIRIN BEER KABUSHIKI KAISHA (JP) 2006-09-28 US disclosed
EP-1614676-A1 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2006-01-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217426-A1 Compound inhibiting in vivo phosphorous transport and medicine containing the same SLC10A6, SLC7A1, SLC10A1 KDM4E 4468/4885MAPT 4195/4885HPGD 2509/4885
US-20120115851-A1 COMPOUND INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICINE CONTAINING THE SAME SLC34A1, SLC34A2, SLC20A2 KDM4E 4535/4885MAPT 4648/4885HPGD 2407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.